Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Market Research Future | PRODUCT CODE: 1457897

Cover Image

PUBLISHER: Market Research Future | PRODUCT CODE: 1457897

Europe Pen Needles Market Research Report - Forecast to 2032

PUBLISHED:
PAGES: 104 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2950
PDF (Multi User License)
USD 3950
PDF (Enterprise License)
USD 5250

Add to Cart

Europe Pen Needles Market Research Report Forecast to 2032

Market Overview

Europe Pen Needles Market is anticipated to register a significant CAGR of 8.61% by 2032. A pen needle is a medical device used in conjunction with injection pens to administer medications by subcutaneous injection. Injection pens are commonly used for the self-administration of insulin by individuals with diabetes, as well as for other injectable medications. Pen needles are attached to the injection pen and are designed to deliver the medication beneath the skin.

The Europe pen needle market is predicted to expand due to increasing prevalence of diabetes, obesity, and other chronic diseases rising awareness of self-administration, and patient preference for pen devices, However, regulatory challenges is limiting market expansion. technological innovation and patient-centric solutions on the other hand, boosts the market's attractiveness. The Europe pen needle market has experienced notable expansion, driven significantly by the rising awareness of self-administration of injectable medications.

Market Segmentation

Based on brand, the Europe pen needles market has been segmented into standard pen needle and safety pen needle. The standard pen needle segment held the largest market in 2022 and is the fastest growing segment during the forecast period.

Based on needle length, the Europe pen needle market has been segmented into 4mm, 5mm, 6mm, 8mm, 10mm and 12.7mm. The 4mm segment held the largest market in 2022 and is the fastest growing segment during the forecast period.

Based on application, the Europe pen needle market has been segmented into insulin therapy, GLP-1 therapy, growth hormone therapy, osteoporosis, and others. The insulin therapy segment held the largest market in 2022 and is the fastest growing segment during the forecast period.

Based on distribution channel, the Europe pen needle market has been segmented into direct sales and distributors. The distributors segment held the largest market in 2022 and is the fastest growing segment during the forecast period.

Based on end user, the Europe pen needle market has been segmented into hospitals & clinics, homecare settings, and others. The homecare settings segment held the largest market in 2022 and is the fastest growing segment during the forecast period.

The Europe pen needles market is segmented into the France and Rest of Europe. The Rest of Europe held the largest market share of 82.99% based on region and is anticipated to dominate the overall needle pen market during the forecast period.

Major Players

The key players operating in the market are Novo Nordisk A/S, Terumo Corporation, Embecta Corp., Ypsomed Holdings AG, MTD Medical Technology and Devices, Novo Nordisk A/S, Terumo Corporation, Embecta Corp., Ypsomed Holdings AG, and MTD Medical Technology and Devices.

TABLE OF CONTENTS

1EXECUTIVE SUMMARY

2MARKET INTRODUCTION

  • 2.1DEFINITION
  • 2.2SCOPE OF THE STUDY
  • 2.3RESEARCH OBJECTIVE
  • 2.4MARKET STRUCTURE

3RESEARCH METHODOLOGY

  • 3.1OVERVIEW
  • 3.2DATA FLOW
    • 3.2.1DATA MINING PROCESS
  • 3.3PURCHASED DATABASE:
  • 3.4SECONDARY SOURCES:
    • 3.4.1SECONDARY RESEARCH DATA FLOW:
  • 3.5PRIMARY RESEARCH:
    • 3.5.1PRIMARY RESEARCH DATA FLOW:
    • 3.5.2PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.6APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1REVENUE ANALYSIS APPROACH
  • 3.7DATA FORECASTING
    • 3.7.1DATA FORECASTING TECHNIQUE
  • 3.8DATA END USERLING
    • 3.8.1MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2DATA END USERLING:
  • 3.9TEAMS AND ANALYST CONTRIBUTION

4MARKET DYNAMICS

  • 4.1INTRODUCTION
  • 4.2DRIVERS
    • 4.2.1INCREASING PREVALENCE OF DIABETES, OBESITY, AND OTHER CHRONIC DISEASES
    • 4.2.2RISING AWARENESS OF SELF-ADMINISTRATION
    • 4.2.3PATIENT PREFERENCE FOR PEN DEVICES
  • 4.3RESTRAINTS
    • 4.3.1REGULATORY CHALLENGES
  • 4.4OPPORTUNITY
    • 4.4.1TECHNOLOGICAL INNOVATION AND PATIENT-CENTRIC SOLUTIONS

5MARKET FACTOR ANALYSIS

  • 5.1VALUE CHAIN ANALYSIS
    • 5.1.1R&D
    • 5.1.2MANUFACTURING
    • 5.1.3DISTRIBUTION AND SALES
    • 5.1.4POST-SALES MONITORING
  • 5.2PORTER'S FIVE FORCES MODEL
    • 5.2.1THREAT OF NEW ENTRANTS
    • 5.2.2BARGAINING POWER OF SUPPLIERS
    • 5.2.3THREAT OF SUBSTITUTES
    • 5.2.4BARGAINING POWER OF BUYERS
    • 5.2.5INTENSITY OF RIVALRY
  • 5.3IMPACT OF COVID-19 ON THE EUROPE PEN NEEDLE MARKET
    • 5.3.1IMPACT ON SUPPLY CHAIN
    • 5.3.2IMPACT ON KEY PLAYERS
    • 5.3.3IMPACT ON DEMAND AND SUPPLY

6EUROPE PEN NEEDLES MARKET, BY PRODUCT

  • 6.1OVERVIEW
  • 6.2STANDARD PEN NEEDLE
  • 6.3SAFETY PEN NEEDLE

7EUROPE PEN NEEDLES MARKET, BY NEEDLE LENGTH

  • 7.1OVERVIEW
  • 7.24MM
  • 7.35MM
  • 7.46MM
  • 7.58MM
  • 7.610MM
  • 7.712.7MM

8EUROPE PEN NEEDLE MARKET, BY APPLICATION

  • 8.1OVERVIEW
  • 8.2INSULIN THERAPY
  • 8.3GLP-1 THERAPY
  • 8.4GROWTH HORMONE THERAPY
  • 8.5OSTEOPOROSIS
  • 8.6OTHERS

9EUROPE PEN NEEDLE MARKET, BY DISTRIBUTION CHANNEL

  • 9.1OVERVIEW
  • 9.2DIRECT SALES
  • 9.3DISTRIBUTORS

10EUROPE PEN NEEDLE MARKET, BY END USER

  • 10.1OVERVIEW
  • 10.2HOSPITALS & CLINICS
  • 10.3HOMECARE SETTINGS
  • 10.4OTHERS

11EUROPE PEN NEEDLE MARKET, BY REGION

  • 11.1OVERVIEW
  • 11.2EUROPE
    • 11.2.1FRANCE
    • 11.2.2REST OF EUROPE

12COMPETITIVE LANDSCAPE

  • 12.1INTRODUCTION
  • 12.2MARKET SHARE ANALYSIS, 2022
  • 12.3COMPETITOR DASHBOARD
  • 12.4PUBLIC PLAYERS STOCK SUMMARY
  • 12.5COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 12.6KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 12.6.1PRODUCT LAUNCH/PRODUCT APPROVAL

13COMPANY PROFILES

  • 13.1NOVO NORDISK A/S
    • 13.1.1COMPANY OVERVIEW
    • 13.1.2FINANCIAL OVERVIEW
    • 13.1.3PRODUCTS OFFERED
    • 13.1.4KEY DEVELOPMENTS
    • 13.1.5SWOT ANALYSIS
    • 13.1.6KEY STRATEGIES
  • 13.2TERUMO CORPORATION
    • 13.2.1COMPANY OVERVIEW
    • 13.2.2FINANCIAL OVERVIEW
    • 13.2.3PRODUCTS OFFERED
    • 13.2.4KEY DEVELOPMENTS
    • 13.2.5SWOT ANALYSIS
    • 13.2.6KEY STRATEGIES
  • 13.3NIPRO EUROPE GROUP COMPANIES
    • 13.3.1COMPANY OVERVIEW
    • 13.3.2FINANCIAL OVERVIEW
    • 13.3.3PRODUCTS OFFERED
    • 13.3.4KEY DEVELOPMENTS
    • 13.3.5SWOT ANALYSIS
    • 13.3.6KEY STRATEGIES
  • 13.4SHANGHAI BEIPU MEDICAL CO., LTD.
    • 13.4.1COMPANY OVERVIEW
    • 13.4.2FINANCIAL OVERVIEW
    • 13.4.3PRODUCTS OFFERED
    • 13.4.4KEY DEVELOPMENTS
    • 13.4.5KEY STRATEGIES
  • 13.5PROMISEMED MEDICAL DEVICES INC.
    • 13.5.1COMPANY OVERVIEW
    • 13.5.2FINANCIAL OVERVIEW
    • 13.5.3PRODUCTS OFFERED
    • 13.5.4KEY DEVELOPMENTS
    • 13.5.5KEY STRATEGIES
  • 13.6TAECHANG INDUSTRIAL CO., LTD.
    • 13.6.1COMPANY OVERVIEW
    • 13.6.2FINANCIAL OVERVIEW
    • 13.6.3PRODUCTS OFFERED
    • 13.6.4KEY DEVELOPMENTS
    • 13.6.5KEY STRATEGIES
  • 13.7VITREX MEDICAL A/S
    • 13.7.1COMPANY OVERVIEW
    • 13.7.2FINANCIAL OVERVIEW
    • 13.7.3PRODUCTS OFFERED
    • 13.7.4KEY DEVELOPMENTS
    • 13.7.5KEY STRATEGIES
  • 13.8EMBECTA CORP.
    • 13.8.1COMPANY OVERVIEW
    • 13.8.2FINANCIAL OVERVIEW
    • 13.8.3PRODUCTS OFFERED
    • 13.8.4KEY DEVELOPMENTS
    • 13.8.5SWOT ANALYSIS
    • 13.8.6KEY STRATEGY
  • 13.9YPSOMED HOLDING AG
    • 13.9.1COMPANY OVERVIEW
    • 13.9.2FINANCIAL OVERVIEW
    • 13.9.3PRODUCTS OFFERED
    • 13.9.4KEY DEVELOPMENTS
    • 13.9.5SWOT ANALYSIS
    • 13.9.6KEY STRATEGY
  • 13.10MTD MEDICAL TECHNOLOGY AND DEVICES
    • 13.10.1COMPANY OVERVIEW
    • 13.10.2FINANCIAL OVERVIEW
    • 13.10.3PRODUCTS OFFERED
    • 13.10.4KEY DEVELOPMENTS
    • 13.10.5KEY STRATEGIES
  • 13.11OWEN MUNFORD
    • 13.11.1COMPANY OVERVIEW
    • 13.11.2FINANCIAL OVERVIEW
    • 13.11.3PRODUCTS OFFERED
    • 13.11.4KEY DEVELOPMENTS
    • 13.11.5KEY STRATEGIES

LIST OF TABLES

  • TABLE 1 QFD END USERLING FOR MARKET SHARE ASSESSMENT 29
  • TABLE 2 EUROPE: PEN NEEDLES MARKET, BY PRODUCT, 2019-2032 (USD MILLION) 46
  • TABLE 3 EUROPE PEN NEEDLES MARKET, FOR STANDARD PEN NEEDLE, BY REGION, 2019-2032 (USD MILLION) 46
  • TABLE 4 EUROPE PEN NEEDLES MARKET, FOR SAFETY PEN NEEDLE, BY REGION, 2019-2032 (USD MILLION) 47
  • TABLE 5 EUROPE PEN NEEDLE MARKET, BY NEEDLE LENGTH, 2019-2032 (USD MILLION) 50
  • TABLE 6 EUROPE PEN NEEDLE MARKET, BY 4MM, 2019-2032 (USD MILLION) 50
  • TABLE 7 EUROPE PEN NEEDLE MARKET, BY 5MM, 2019-2032 (USD MILLION) 50
  • TABLE 8 EUROPE PEN NEEDLE MARKET, BY 6MM, 2019-2032 (USD MILLION) 51
  • TABLE 9 EUROPE PEN NEEDLE MARKET, BY 8MM, 2019-2032 (USD MILLION) 51
  • TABLE 10 EUROPE PEN NEEDLE MARKET, BY 10MM, 2019-2032 (USD MILLION) 51
  • TABLE 11 EUROPE PEN NEEDLE MARKET, BY 12.7MM, 2019-2032 (USD MILLION) 52
  • TABLE 12 EUROPE PEN NEEDLE MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 55
  • TABLE 13 EUROPE PEN NEEDLES MARKET, BY INSULIN THERAPY, 2019-2032 (USD MILLION) 56
  • TABLE 14 EUROPE PEN NEEDLES MARKET, BY GLP-1 THERAPY, 2019-2032 (USD MILLION) 56
  • TABLE 15 EUROPE PEN NEEDLES MARKET, BY GROWTH HORMONE THERAPY, 2019-2032 (USD MILLION) 56
  • TABLE 16 EUROPE PEN NEEDLES MARKET, BY OSTEOPOROSIS, 2019-2032 (USD MILLION) 57
  • TABLE 17 EUROPE PEN NEEDLES MARKET, BY OTHERS, 2019-2032 (USD MILLION) 57
  • TABLE 18 EUROPE PEN NEEDLE MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION) 59
  • TABLE 19 EUROPE PEN NEEDLES MARKET, BY DIRECT SALES, 2019-2032 (USD MILLION) 59
  • TABLE 20 EUROPE PEN NEEDLES MARKET, BY DISTRIBUTORS, 2019-2032 (USD MILLION) 59
  • TABLE 21 EUROPE PEN NEEDLE MARKET, BY END USER, 2019-2032 (USD MILLION) 62
  • TABLE 22 EUROPE PEN NEEDLES MARKET, BY HOSPITALS & CLINICS, 2019-2032 (USD MILLION) 62
  • TABLE 23 EUROPE PEN NEEDLES MARKET, BY HOMECARE SETTINGS, 2019-2032 (USD MILLION) 63
  • TABLE 24 EUROPE PEN NEEDLES MARKET, BY OTHERS, 2019-2032 (USD MILLION) 63
  • TABLE 25 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2019-2032 (USD MILLION) 65
  • TABLE 26 EUROPE: PEN NEEDLES MARKET, BY PRODUCT, 2019-2032 (USD MILLION) 66
  • TABLE 27 EUROPE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2019-2032 (USD MILLION) 66
  • TABLE 28 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 66
  • TABLE 29 EUROPE: PEN NEEDLES MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION) 67
  • TABLE 30 EUROPE: PEN NEEDLES MARKET, BY END USER, 2019-2032 (USD MILLION) 67
  • TABLE 31 FRANCE: PEN NEEDLES MARKET, BY PRODUCT, 2019-2032 (USD MILLION) 67
  • TABLE 32 FRANCE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2019-2032 (USD MILLION) 68
  • TABLE 33 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 68
  • TABLE 34 FRANCE: PEN NEEDLES MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION) 68
  • TABLE 35 FRANCE: PEN NEEDLES MARKET, BY END USER, 2019-2032 (USD MILLION) 69
  • TABLE 36 REST OF EUROPE: PEN NEEDLES MARKET, BY PRODUCT, 2019-2032 (USD MILLION) 69
  • TABLE 37 REST OF EUROPE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2019-2032 (USD MILLION) 69
  • TABLE 38 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 70
  • TABLE 39 REST OF EUROPE: PEN NEEDLES MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD MILLION) 70
  • TABLE 40 REST OF EUROPE: PEN NEEDLES MARKET, BY END USER, 2019-2032 (USD MILLION) 70
  • TABLE 41 PUBLIC PLAYERS STOCK SUMMARY 74
  • TABLE 42 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 74
  • TABLE 43 PRODUCT LAUNCH/PRODUCT APPROVAL 75
  • TABLE 44 NOVO NORDISK A/S: PRODUCTS OFFERED 77
  • TABLE 45 TERUMO CORPORATION: PRODUCTS OFFERED 81
  • TABLE 46 TERUMO CORPORATION: KEY DEVELOPMENTS 82
  • TABLE 47 NIPRO EUROPE GROUP COMPANIES: PRODCUTS OFFERED 84
  • TABLE 48 SHANGHAI BEIPU MEDICAL CO., LTD.: PRODUCTS OFFERED 85
  • TABLE 49 PROMISEMED MEDICAL DEVICES INC.: PRODUCTS OFFERED 87
  • TABLE 50 TAECHANG INDUSTRIAL CO., LTD.: PRODCUTS OFFERED 89
  • TABLE 51 VITREX MEDICAL A/S: PRODCUTS OFFERED 90
  • TABLE 52 EMBECTA CORP.: PRODCUTS OFFERED 93
  • TABLE 53 YPSOMED HOLDING AG: PRODUCTS OFFERED 96
  • TABLE 54 MTD MEDICAL TECHNOLOGY AND DEVICES: PRODUCTS OFFERED 99
  • TABLE 55 MTD MEDICAL TECHNOLOGY AND DEVICES: KEY DEVELOPMENTS 100
  • TABLE 56 OWEN MUNFORD: PRODUCTS OFFERED 101
  • TABLE 57 OWEN MUNFORD:KEY DEVELOPMENTS 102

LIST OF FIGURES

  • FIGURE 1EUROPE PEN NEEDLE MARKET: STRUCTURE16
  • FIGURE 2EUROPE PEN NEEDLE MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)33
  • FIGURE 3DRIVER IMPACT ANALYSIS (2023-2032)35
  • FIGURE 4RESTRAINT IMPACT ANALYSIS (2022-2032)36
  • FIGURE 5VALUE CHAIN ANALYSIS OF THE EUROPE PEN NEEDLE MARKET38
  • FIGURE 6PORTER'S FIVE FORCES ANALYSIS: EUROPE PEN NEEDLE MARKET40
  • FIGURE 7EUROPE PEN NEEDLES MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)45
  • FIGURE 8EUROPE PEN NEEDLES MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION)45
  • FIGURE 9EUROPE PEN NEEDLES MARKET SHARE (%), BY PRODUCT, 202246
  • FIGURE 10EUROPE PEN NEEDLE MARKET, NEEDLE LENGTH SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)48
  • FIGURE 11EUROPE PEN NEEDLE MARKET, BY NEEDLE LENGTH, 2022 & 2032 (USD MILLION)49
  • FIGURE 12EUROPE PEN NEEDLE MARKET SHARE (%), BY NEEDLE LENGTH, 202249
  • FIGURE 13EUROPE PEN NEEDLE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)53
  • FIGURE 14EUROPE PEN NEEDLE MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION)54
  • FIGURE 15EUROPE PEN NEEDLE MARKET SHARE (%), BY APPLICATION, 202254
  • FIGURE 16EUROPE PEN NEEDLE MARKET, DISTRIBUTION CHANNEL SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)58
  • FIGURE 17EUROPE PEN NEEDLE MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2032 (USD MILLION)58
  • FIGURE 18EUROPE PEN NEEDLE MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 202259
  • FIGURE 19EUROPE PEN NEEDLE MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)61
  • FIGURE 20EUROPE PEN NEEDLE MARKET, BY END USER, 2022 & 2032 (USD MILLION)61
  • FIGURE 21EUROPE PEN NEEDLE MARKET SHARE (%), BY END USER, 202262
  • FIGURE 22EUROPE MARKET ANALYSIS: EUROPE PEN NEEDLES MARKET, 2019-2023(USD MILLION)64
  • FIGURE 23EUROPE: EUROPE PEN NEEDLES MARKET SHARE, BY COUNTRY, 2022 (% SHARE)65
  • FIGURE 24EUROPE: EUROPE PEN NEEDLES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)65
  • FIGURE 25EUROPE PEN NEEDLES MARKET PLAYERS: COMPETITIVE ANALSIS, 202272
  • FIGURE 26COMPETITOR DASHBOARD: EUROPE PEN NEEDLES MARKET73
  • FIGURE 27NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT77
  • FIGURE 28NOVO NORDISK A/S: SWOT ANALYSIS78
  • FIGURE 29TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT81
  • FIGURE 30TERUMO CORPORATION: SWOT ANALYSIS82
  • FIGURE 31NIPRO EUROPE GROUP COMPANIES: SWOT ANALYSIS84
  • FIGURE 32EMBECTA CORP.: FINANCIAL OVERVIEW SNAPSHOT93
  • FIGURE 33EMBECTA CORP.: SWOT ANALYSIS94
  • FIGURE 34YPSOMED HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT96
  • FIGURE 35YPSOMED HOLDING AG: SWOT ANALYSIS97
  • FIGURE 36MTD MEDICAL TECHNOLOGY AND DEVICES: FINANCIAL OVERVIEW SNAPSHOT99
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!